Pharmacological profile of droxicam

Area of Science:

• Pharmacology
• Medicinal Chemistry

Background:

• Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
• Developing NSAIDs with improved efficacy and safety profiles is an ongoing research area.

Purpose of the Study:

• To evaluate the pharmacological profile of droxicam, a novel NSAID.
• To compare the efficacy and safety of droxicam with existing NSAIDs.

Main Methods:

• In vivo studies assessing anti-inflammatory, anti-arthritic, analgesic, and antipyretic activities.
• Ex vivo platelet aggregation inhibition assay.
• General pharmacology screening including cardiovascular, respiratory, and behavioral effects.
• Gastrointestinal tolerance and lesion induction studies.

Main Results:

• Droxicam demonstrated significant anti-inflammatory activity, comparable to piroxicam and superior to phenylbutazone, isoxicam, and suprofen.
• In anti-arthritic models, droxicam was as effective as piroxicam.
• Droxicam exhibited superior analgesic activity compared to acetylsalicylic acid, dipyrone, isoxicam, and phenylbutazone.
• Antipyretic activity of droxicam was greater than acetylsalicylic acid, dipyrone, and 4-aminoantipyrine.
• Droxicam showed potent inhibition of ex vivo platelet aggregation and peritoneal capillary permeability.
• High doses of droxicam did not affect cardiovascular, respiratory, or behavioral parameters.
• Droxicam exhibited significantly better gastrointestinal tolerance and a 10-fold lower gastrolesive potential than piroxicam.

Conclusions:

• Droxicam possesses a broad spectrum of pharmacological activities, including potent anti-inflammatory, analgesic, and antipyretic effects.
• Droxicam demonstrates a favorable safety profile, particularly regarding gastrointestinal tolerance, making it a promising therapeutic agent.